Winch Advisory Services’s Heron Therapeutics HRTX Stock Holding History

Winch Advisory Services’s Portfolio HRTX Stock Details HRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$427	Hold	1,000	–	–	﹤0.01%	524
2026 Q1	$800	Hold	1,000	–	–	﹤0.01%	469
2025 Q4	$1.3K	Hold	1,000	–	–	﹤0.01%	448
2025 Q3	$1.26K	Hold	1,000	–	–	﹤0.01%	453
2025 Q2	$2.07K	Hold	1,000	–	–	﹤0.01%	406
2025 Q1	$2.2K	Hold	1,000	–	–	﹤0.01%	408
2024 Q4	$1.53K	Hold	1,000	–	–	﹤0.01%	460
2024 Q3	$1.99K	Hold	1,000	–	–	﹤0.01%	377
2024 Q2	$3.5K	Hold	1,000	–	–	﹤0.01%	339
2024 Q1	$2.77K	Hold	1,000	–	–	﹤0.01%	351
2023 Q4	$1.7K	Hold	1,000	–	–	﹤0.01%	372
2023 Q3	$1K	Hold	1,000	–	–	﹤0.01%	393
2023 Q2	$1K	Hold	1,000	–	–	﹤0.01%	393
2023 Q1	$2K	Hold	1,000	–	–	﹤0.01%	353
2022 Q4	$3K	Hold	1,000	–	–	﹤0.01%	316
2022 Q3	$4K	Hold	1,000	–	–	﹤0.01%	284
2022 Q2	$3K	Hold	1,000	–	–	﹤0.01%	324
2022 Q1	$6K	Hold	1,000	–	–	﹤0.01%	299
2021 Q4	$9K	Hold	1,000	–	–	﹤0.01%	271
2021 Q3	$11K	Hold	1,000	–	–	﹤0.01%	263
2021 Q2	$16K	Hold	1,000	–	–	0.01%	231
2021 Q1	$16K	Hold	1,000	–	–	0.01%	209
2020 Q4	$21K	Hold	1,000	–	–	0.01%	156
2020 Q3	$15K	Hold	1,000	–	–	0.01%	168
2020 Q2	$15K	Buy	+1,000	New	+$16.4K	0.01%	159
2020 Q1	–	Sell	-939	Closed	-$22K	–	359
2019 Q4	$22K	Hold	939	–	–	0.01%	150
2019 Q3	$17K	Buy	+939	New	+$17.3K	0.01%	153
2018 Q2	–	Sell	-100	Closed	-$3K	–	353
2018 Q1	$3K	Sell	100 -200	-67%	-$4.54K	﹤0.01%	248
2017 Q4	$5K	Buy	+300	New	+$4.89K	﹤0.01%	219

Other funds holding HRTX

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Clearline Capital New York $1.68B AUM 53.07% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Tejara Capital London, United Kingdom $243M AUM 9.84% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

JAM

JW Asset Management Miami Beach, Florida $320M AUM 140.1% 1-Year Est. Return

Winch Advisory Services's HRTX Position: Q2 2026 in Review

Winch Advisory Services held its Heron Therapeutics (HRTX) position steady in Q2 2026 at 1,000 shares worth $427. The position accounts for ﹤0.01% of the portfolio, ranked #524.

Winch Advisory Services first reported a position in HRTX in Q4 2017 and has held it in 29 quarters since. The position peaked at $22K in Q4 2019. 163 funds tracked by Wall St. Rank hold HRTX as of Q2 2026.

Winch Advisory Services held 1,000 shares of Heron Therapeutics worth $427 as of Q2 2026.
Winch Advisory Services left its Heron Therapeutics share count unchanged in Q2 2026.
Heron Therapeutics made up ﹤0.01% of Winch Advisory Services's portfolio in Q2 2026, its #524 holding.
Winch Advisory Services first reported a position in Heron Therapeutics in Q4 2017 and has held it in 29 quarters since.
Winch Advisory Services's Heron Therapeutics position peaked at $22K in Q4 2019.
163 funds tracked by Wall St. Rank held Heron Therapeutics as of Q2 2026.

Based on Winch Advisory Services's 13F filing for Q2 2026, filed 6 Aug 2026.